BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1716620)

  • 21. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
    Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
    Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Post-transfusional hepatitis].
    González A; Esteban JI
    Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis C virus and organ donor cards.
    Rouse A; Goodrick MJ; Anderson NA; Fraser ID; Pearson V
    BMJ; 1992 Feb; 304(6825):502. PubMed ID: 1372193
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevalence and risk factors of hepatitis C infection after cardiac surgery in childhood before and after blood donor screening.
    Vogt M; Mühlbauer F; Braun SL; Lang T; Busch R; Lange R; Frösner G; Hess J
    Infection; 2004 Jun; 32(3):134-7. PubMed ID: 15188071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for hepatitis C virus antibody.
    Lancet; 1989 Aug; 2(8661):505. PubMed ID: 2570213
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis C virus : prevalence in Lebanese blood donors and brief overview of the disease.
    Araj GF; Kfoury-Baz EE; Barada KA; Nassif RE; Alami SY
    J Med Liban; 1995; 43(1):11-6. PubMed ID: 8676356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to hepatitis C virus and surrogate marker testing of blood donors to prevent non-A, non-B hepatitis.
    Kakaiya R; Stephans J; Carnahan G; Ahmed P; Miller WV
    Transfusion; 1991 Oct; 31(8):780-1. PubMed ID: 1656555
    [No Abstract]   [Full Text] [Related]  

  • 28. Screening for hepatitis C virus antibody in plasma for fractionation.
    Habibi B; Garretta M
    Lancet; 1990 Apr; 335(8693):855-6. PubMed ID: 1969577
    [No Abstract]   [Full Text] [Related]  

  • 29. [Post-transfusion non-A, non-B hepatitis: towards risk zero].
    de Andrade Júnior DR; de Andrade DR
    Arq Gastroenterol; 1992; 29(1):1-4. PubMed ID: 1284884
    [No Abstract]   [Full Text] [Related]  

  • 30. [International status of anti-HCV screening and conclusions].
    Habibi B
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):379-82. PubMed ID: 2177603
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibodies to hepatitis C virus in blood donors.
    Sood G; Chauhan A; Sehgal S; Agnihotri S; Dilawari JB
    Indian J Gastroenterol; 1992 Jan; 11(1):44. PubMed ID: 1372593
    [No Abstract]   [Full Text] [Related]  

  • 32. Low rate of hepatitis C virus antibodies in blood donors and pregnant women from Niger.
    Develoux M; Meynard D; Delaporte E
    Trans R Soc Trop Med Hyg; 1992; 86(5):553. PubMed ID: 1282279
    [No Abstract]   [Full Text] [Related]  

  • 33. [Non-specific reactions of ELISA test for the detection of the hepatitis C virus in blood donors. Immunologic considerations].
    Diallo A; Lazizi Y; Le Guenno B; Pillot J
    Presse Med; 1991 Mar; 20(8):383. PubMed ID: 1826766
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anti-HVC antibodies and raw-material plasma: reflections and strategy].
    Avenard G; Maquin A; Schoeffter C; Mangin C
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):351-4. PubMed ID: 2177597
    [No Abstract]   [Full Text] [Related]  

  • 35. HCV confirmatory testing of blood donors.
    Crawford RJ; Frame WD; Mitchell R
    Lancet; 1992 Apr; 339(8798):928. PubMed ID: 1372948
    [No Abstract]   [Full Text] [Related]  

  • 36. Screening of blood donations for hepatitis C virus antibody.
    Kimber RJ
    Med J Aust; 1990 Jun; 152(11):613. PubMed ID: 2112223
    [No Abstract]   [Full Text] [Related]  

  • 37. Screening of blood donors for non-A non-B hepatitis.
    Lancet; 1981 Jul; 2(8237):73. PubMed ID: 6113444
    [No Abstract]   [Full Text] [Related]  

  • 38. Administration of immune serum globulin following exposure to hepatitis C virus.
    Miller MA; Orenstein P; Amihod B
    Clin Infect Dis; 1993 Feb; 16(2):335. PubMed ID: 7680238
    [No Abstract]   [Full Text] [Related]  

  • 39. Measurement of anti-GOR antibodies in prevention of post-transfusion non-A, non-B hepatitis.
    Yoshizawa H; Nojiri N; Takahashi K
    Lancet; 1991 Jan; 337(8732):47-8. PubMed ID: 1670664
    [No Abstract]   [Full Text] [Related]  

  • 40. Developments in hepatitis epidemiology: hepatitis C virus.
    Mutimer D
    Br J Hosp Med; 1995 Nov 15-Dec 12; 54(10):484-5. PubMed ID: 8574488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.